Loading clinical trials...

Asymptomatic COVID-19 Trial | Clinical Trials | Clareo Health

WITHDRAWNPhase 2NCT04374552

Asymptomatic COVID-19 Trial

The coronavirus disease-2019 (COVID-19) is spreading throughout the United States. While there are no known therapies to treat those who have become sick, there have been some reports that a medicatio...

Lead sponsor: Rutgers, The State University of New Jersey•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Cognitive-Sensorimotor Function in Long-COVID

NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

NCT05141058 · SARS-CoV-2 Infection

RECRUITINGPhase 3

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140 · COVID-19 SARS-CoV-2 Infection

RECRUITING

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT06160128 · COVID-19, SARS-CoV-2 Infection, RSV, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2020Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE2

Enrollment—

Start dateMay 2020

Last updatedNov 2, 2020

Condition

SARS-CoV-2 Infection

Locations shown

Robert Wood Johnson University Hospital

New Brunswick, New Jersey

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions